4.11 CheckMate 274, PARADIGM-HF/Ernesto, POLO, & an AI Approach to Reducing Knee Pain
Today's episode is a compilation of a few short m…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
July 31, 202154m 18sExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Today's episode is a compilation of a few short monologues. We provide an oncologist's evidence-based medicine perspective on four papers: CheckMate 274, adjuvant nivolumab in urothelial cancer; PARADIGM-HF/Entresto; the POLO trial, olaparib in pancreas cancer; and the paper "An algorithmic approach to reducing unexplained pain disparities in underserved populations".
CheckMate 274: doi.org/10.1056/NEJMoa2034442
PARADIGM-HF: doi.org/10.1056/nejmoa1409077
POLO: doi.org/10.1056/NEJMoa1903387
Knee pain: doi.org/10.1038/s41591-020-01192-7
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
Topics
medicineoncologyhealthpolicy